ArticleBMJ open2026
Determinants of human papillomavirus vaccine non-uptake among adolescent girls in Ethiopia: evidence from National Immunization Survey.
Article in BMJ open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo assess determinants of human papillomavirus (HPV) vaccine non-uptake among adolescent girls in Ethiopia.
designCommunity-based cross-sectional study.
settingEthiopia.
participantsA weighted sample of 5341 adolescent girls.
methodsA secondary analysis was conducted using the 2024 Ethiopian National Immunization Evaluation Survey dataset. A two-stage stratified sampling technique was used to select 467 enumeration areas (EAs). Within each EA, 30 households with adolescent girls aged 15-18 were systematically selected. Data were collected using a semi-structured questionnaire. Mixed-effects logistic regression was used to identify individual-level and/or household-level, and community-level determinants. Associations were presented using adjusted ORs with 95% CIs and statistical significance was set at p<0.05.
resultsIndividual and household-level determinants of HPV vaccine non-uptake include age 17-18 years (adjusted OR (AOR)=1.41; 95% CI 1.16 to 1.72), illiteracy (AOR=3.03; 95% CI 2.14 to 4.28), not currently attending school (AOR=2.84; 95% CI 2.24 to 3.60), poor knowledge (AOR=8.91; 95% CI 6.63 to 11.99), unfavourable attitude (AOR=4.24; 95% CI 3.34 to 5.37) and living in the poorest households (AOR=1.48; 95% CI 1.04 to 2.10). Community-level determinants were urban residence (AOR=1.40; 95% CI 1.01 to 1.95); and living in Addis Ababa (AOR=2.73; 95% CI 1.29 to 5.74), Afar (AOR=4.73; 95% CI 2.08 to 10.77), Dire Dawa (AOR=2.69; 95% CI 1.21 to 5.98), Harari (AOR=2.09; 95% CI 1.05 to 4.14) and Somali (AOR=3.68; 95% CI 1.61 to 8.38).
conclusionThe determinants of HPV vaccine non-uptake were older age (17-18), illiteracy, school non-attendance, poor knowledge, unfavourable attitude, living in the poorest households, urban residence and living in Addis Ababa, Afar, Dire Dawa, Harari and Somali. The findings call for improved health literacy, knowledge and attitude through health extension programmes and targeted outreach in underserved urban and pastoralist settings.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.